All Clinical & Diagnostics articles – Page 10
-
NewsUltra-low dose CT aids pneumonia diagnosis in immunocompromised patients
Denoised ultra-low dose CT can effectively diagnose pneumonia in immunocompromised patients using only 2% of the radiation dose of standard CT, according to a study.
-
NewsInhaled COVID vaccine study begins recruitment for phase-2 human trials
Researchers have started a phase-2 clinical trial on a next-generation, inhaled COVID-19 vaccine. Findings from the phase-1 trial indicate that the vaccine is more effective at inducing immune responses than traditional injected vaccines are.
-
NewsScientists develop low-cost handheld sensor test for airborne bird flu
Researchers have developed a prototype sensor that detects a virus that causes bird flu (H5N1) in air samples. The low-cost handheld sensor detects the virus at levels below an infectious dose and could lead to rapid aerosol testing for airborne avian influenza.
-
FeaturesUrinary tract infections: addressing the gender gap and advancing microbial insights
Urinary tract infections (UTIs) are among the most common bacterial infections worldwide, disproportionately affecting women and contributing to a significant healthcare burden.
-
NewsInsilico Medicine deploys the first bipedal humanoid AI scientist in fully-robotic drug discovery laboratory
Insilico Medicine, a clinical-stage biotechnology company pioneering generative AI for drug discovery and development, has announced the deployment of the first bipedal humanoid in its AI-powered fully-robotic drug discovery laboratory.
-
NewsScientist who deployed glowing stars to detect disease named fellow of the Royal Society of Chemistry
The man who turned the science of glow-in-the-dark stars into ways to detect disease, Professor Richard Willson, has been elected as a fellow of the Royal Society of Chemistry.
-
NewsNew biosensor can detect airborne bird flu in under 5 minutes
A new biosensor for monitoring aerosol particles of H5N1 works within five minutes, preserving the sample of the microbes for further analysis and providing a range of the pathogen concentration levels detected on a farm.
-
NewsA*STAR spin-off NalaGenetics implements nationwide drug reaction screening for leprosy patients in Indonesia
NalaGenetics, a spin-off from A*STAR Genome Institute of Singapore (A*STAR GIS), will be transforming leprosy treatments in Indonesia with a nationwide genetic screening programme with their PGx1301 diagnostic kit.
-
NewsLung abnormalities seen in children and teens with long COVID
An advanced type of MRI uncovers significant lung abnormalities in children and adolescents with long COVID, according to a new study. PREFUL MRI doesn’t require the use of radiation or intravenous contrast agents and can be done while the patient breathes freely.
-
NewsNew paper-based device boosts HIV test accuracy from dried blood samples
Scientists have trialled a more precise medical device to measure HIV viral loads by engineering a paper device with wax-printed patterns that create precise channels and collection spots, ensuring it consistently collects the same volume of blood.
-
NewsPaxlovid’s impact on hospitalization and death in COVID-vaccinated older adults far weaker than previously thought
A new study overturns the assumption that Paxlovid’s effectiveness in reducing COVID-19 hospitalizations and deaths in unvaccinated adults also applies to vaccinated adults.
-
FeaturesThe shifting landscape of the cervicovaginal microbiome in chlamydia infection
Bacterial vaginosis (BV) is a remarkably common condition among women of reproductive age, affecting as many as a third of all women at any given time. Yet it remains surprisingly elusive.
-
NewsMachine learning framework can decipher immune system’s record of past infections
A novel machine learning framework can decipher an individual’s immune system’s record of past infections and diseases, providing a powerful tool with the potential for diagnosing autoimmune disorders, viral infections, and vaccine responses with precision.
-
News1 in 5 older adults get infections after heart surgery, and women have a 60% higher risk
One in five older adults gets an infection up to six months after heart surgery, with women far more likely to develop one, according to two studies which examined thousands of cases of coronary artery bypass grafting.
-
NewsTransforming HIV diagnosis: a low-cost, point-of-care detection solution
A team of researchers has developed an innovative handheld device for human immunodeficiency virus (HIV) detection that combines paper-based sample preparation with real-time isothermal amplification.
-
NewsRapid diagnostic tests improve diagnosis access to indigenous Paraguayan community for Chagas disease
A study has shown that combining rapid diagnostic tests (RDTs) with conventional serological tests proves to be a useful strategy for diagnosing Chagas disease in an indigenous community in the Paraguayan Chaco with its higher prevalence of the disease.
-
NewsInternational team publishes guideline on how to manage fungal infections caused by Candida
The new global guideline for the diagnosis and treatment of Candida infections establishes new standards for managing fungal infections, which affect millions of people worldwide every year.
-
NewsGuarding our seafood: innovative strategies against Vibrio parahaemolyticus
Recent research presents a novel approach to managing the risks posed by Vibrio parahaemolyticus, a common yet hazardous foodborne pathogen in seafood, offering a comprehensive framework for monitoring and mitigating health risks.
-
NewsHarvard Pilgrim Health Care Institute announces launch of Center for Sepsis Epidemiology and Prevention Studies (SEPSIS)
The new Center for Sepsis Epidemiology and Prevention Studies (SEPSIS) is a pioneering center of excellence dedicated to advancing understanding, prevention, and management of sepsis, a life-threatening condition caused by a dysregulated immune response to infection.
-
CareersHow frontline innovation from military labs can fight antimicrobial resistance worldwide
CEO at Presymptom Health, Dr. Iain Miller reveals how research in military laboratories - born out of battlefield demands - is now yielding innovative tech that allows for faster and more accurate detection of infections, even before symptoms appear.